• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗惊厥药在肝性卟啉病中的安全性。

Safety of anticonvulsants in hepatic porphyrias.

作者信息

Reynolds N C, Miska R M

出版信息

Neurology. 1981 Apr;31(4):480-4. doi: 10.1212/wnl.31.4.480.

DOI:10.1212/wnl.31.4.480
PMID:7194443
Abstract

Because acute attacks of porphyria may be precipitated by anticonvulsants, a therapeutic dilemma arises when seizures complicate hepatic porphyria. The list of unsafe agents includes barbiturates, primidone, phenytoin, mephenytoin, ethotoin, ethosuximide, methsuximide, phensuximide, and trimethadione. Agents are considered unsafe if they induce experimental porphyria in animals, and short trials in patients are unreliable for screening. Using drug incubation in chick-embryo hepatocyte culture, we found that porphyrin was increased by carbamazepine, clonazepam, and valproate. These agents should probably be avoided or used with caution in porphyric patients. Alternative approaches to acute porphyric attacks with seizures are discussed.

摘要

由于卟啉症的急性发作可能由抗惊厥药诱发,当癫痫并发肝卟啉症时就会出现治疗困境。不安全药物包括巴比妥类、扑米酮、苯妥英、甲妥英、乙苯妥英、乙琥胺、甲琥胺、苯琥胺和三甲双酮。如果药物在动物中诱发实验性卟啉症,则被认为是不安全的,而在患者中进行的短期试验对于筛查并不可靠。通过在鸡胚肝细胞培养中进行药物孵育,我们发现卡马西平、氯硝西泮和丙戊酸盐可使卟啉增加。在卟啉症患者中,这些药物可能应避免使用或谨慎使用。本文讨论了针对伴有癫痫发作的急性卟啉症发作的替代方法。

相似文献

1
Safety of anticonvulsants in hepatic porphyrias.抗惊厥药在肝性卟啉病中的安全性。
Neurology. 1981 Apr;31(4):480-4. doi: 10.1212/wnl.31.4.480.
2
Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria.
Neurology. 1997 Jul;49(1):97-106. doi: 10.1212/wnl.49.1.97.
3
Acute intermittent porphyria and epilepsy: safety of clonazepam.急性间歇性卟啉病与癫痫:氯硝西泮的安全性
Epilepsia. 1992 Jan-Feb;33(1):108-11. doi: 10.1111/j.1528-1157.1992.tb02291.x.
4
Seizure management in acute hepatic porphyria: risks of valproate and clonazepam.
Neurology. 1980 Jun;30(6):588-92. doi: 10.1212/wnl.30.6.588.
5
Posttraumatic epilepsy and acute intermittent porphyria: effects of phenytoin, carbamazepine, and clonazepam.创伤后癫痫与急性间歇性卟啉病:苯妥英钠、卡马西平和氯硝西泮的作用
Neurology. 1978 Aug;28(8):824-8. doi: 10.1212/wnl.28.8.824.
6
Seizure management in the hepatic porphyrias: results from a cell-culture model of porphyria.肝性卟啉病的癫痫管理:来自卟啉病细胞培养模型的结果
Neurology. 1984 Mar;34(3):399. doi: 10.1212/wnl.34.3.399.
7
Anticonvulsant-induced unclassified porphyria.抗惊厥药诱发的未分类卟啉病。
Int J Biochem. 1980;12(5-6):955-7. doi: 10.1016/0020-711x(80)90191-3.
8
Effect of tiagabine and topiramate on porphyrin metabolism in an in vivo model of porphyria.
Pharmacol Toxicol. 2001 Jul;89(1):15-22. doi: 10.1034/j.1600-0773.2001.d01-130.x.
9
Non-alcoholic steatohepatitis induced by carbamazepine and variegate porphyria.卡马西平与杂合性卟啉病诱发的非酒精性脂肪性肝炎。
Eur J Gastroenterol Hepatol. 2001 Aug;13(8):973-5. doi: 10.1097/00042737-200108000-00018.
10
Drug-induced porphyrin biosynthesis. II. Simple procedure for screening drugs for porphyria-inducing activity.药物诱导的卟啉生物合成。II. 筛选具有卟啉诱导活性药物的简易方法。
Biochem Pharmacol. 1969 Aug;18(8):2009-18. doi: 10.1016/0006-2952(69)90298-6.

引用本文的文献

1
Pharmacokinetic changes of psychotropic drugs in patients with liver disease: implications for dose adaptation.肝病患者精神药物的药代动力学变化:剂量调整的意义。
Drug Saf. 2009;32(7):561-78. doi: 10.2165/00002018-200932070-00003.
2
Levetiracetam in idiopathic generalised epilepsy and porphyria cutanea tarda.左乙拉西坦治疗特发性全身性癫痫和迟发性皮肤卟啉病。
Clin Drug Investig. 2006;26(6):357-9. doi: 10.2165/00044011-200626060-00007.
3
The little imitator--porphyria: a neuropsychiatric disorder.小模仿者——卟啉病:一种神经精神障碍。
J Neurol Neurosurg Psychiatry. 1997 Apr;62(4):319-28. doi: 10.1136/jnnp.62.4.319.
4
Acute intermittent porphyria presenting as epilepsy.以癫痫为表现的急性间歇性卟啉病。
Br Med J (Clin Res Ed). 1986 Apr 5;292(6525):946-7. doi: 10.1136/bmj.292.6525.946.